Endogenous nitric oxide protects against thromboembolism in venules but not in arterioles

Arteriosclerosis, Thrombosis, and Vascular Biology
M A BroedersMirjam G A oude Egbrink

Abstract

Because nitric oxide (NO) inhibits aggregation and adhesion of blood platelets, NO may play a role in platelet-vessel wall interactions. Therefore, the purpose of this study was to investigate the involvement of endogenous NO in thromboembolic processes, as induced by wall puncture, in rabbit mesenteric arterioles and venules (diameters 20 to 43 microm). In venules, inhibition of NO synthase by superfusion of the mesentery with N omega-nitro-L-arginine (L-NA; 0.1 mmol/L) significantly increased the duration of embolization (from 50 seconds to 511 seconds) and the number of emboli produced (from 2 to 11 emboli per vessel), while the median period of time needed to produce an embolus was not influenced. On the contrary, in arterioles, L-NA had no significant effect on embolization (duration of embolization: 426 seconds in the control and 382 seconds in the L-NA group, with 20 and 12 emboli per vessel, respectively). Addition to the L-NA superfusate of L-arginine (L-ARG; 1 mmol/L), the active precursor for endogenous NO synthesis, resulted in a complete reversal of the L-NA effects in venules, while addition of the inactive D-arginine (D-ARG; 1 mmol/L) had no effect. Addition of L-ARG and D-ARG had no significant effect in arterio...Continue Reading

References

Jul 1, 1992·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·W I RosenblumG H Nelson
Oct 1, 1990·British Journal of Pharmacology·M W RadomskiS Moncada
Oct 1, 1990·Journal of Cardiovascular Pharmacology·M OvizeS Renaud
Jan 1, 1991·Basic Research in Cardiology·U Pohl, D Lamontagne
Jul 1, 1990·British Journal of Pharmacology·M G PerssonS Moncada
Jul 1, 1989·Pflügers Archiv : European journal of physiology·M G oude EgbrinkR S Reneman
Aug 1, 1988·British Journal of Pharmacology·J C HoganA H Henderson
May 1, 1973·Microvascular Research·M Intaglietta, W R Tompkins
Mar 1, 1994·The Biochemical Journal·R G Knowles, S Moncada
Jan 1, 1993·Advances in Experimental Medicine and Biology·M W Radomski, S Moncada
Jan 1, 1995·Annual Review of Pharmacology and Toxicology·J M Fukuto, G Chaudhuri
Sep 1, 1994·Annals of Biomedical Engineering·J D Hellums
May 14, 1994·Lancet·E Anggård

❮ Previous
Next ❯

Citations

Mar 8, 2008·Medical & Biological Engineering & Computing·Robert S Reneman, Arnold P G Hoeks
Mar 23, 2013·Current Rheumatology Reports·Chieko Mineo
Feb 19, 2000·Prostaglandins & Other Lipid Mediators·S C TrompM G oude Egbrink
Sep 5, 2013·Proceedings of the National Academy of Sciences of the United States of America·Nicholas S KirkbyTimothy D Warner
Feb 4, 2010·Molecular Biology of the Cell·Donald R Senger
Oct 28, 2008·American Journal of Physiology. Heart and Circulatory Physiology·Liang-Wu FuJohn C Longhurst
May 13, 2014·Biochemistry Research International·Meral EkimHasan Ekim
Dec 14, 2011·Free Radical Biology & Medicine·Peter R Kvietys, D Neil Granger
Sep 24, 2015·Cellular and Molecular Life Sciences : CMLS·Xiaohong ShuBrant E Isakson
Jul 23, 2003·Journal of Thrombosis and Haemostasis : JTH·J E Freedman, J Loscalzo
May 27, 2020·Translational Research : the Journal of Laboratory and Clinical Medicine·Monica A BrayRolando E Rumbaut
Jun 18, 2019·Journal of Theoretical Biology·Janani Srree Murallidharan, Stephen J Payne
Oct 30, 2007·Free Radical Biology & Medicine·Mutay Aslan, Bruce A Freeman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.